{"protocolSection": {"identificationModule": {"nctId": "NCT02517047", "orgStudyIdInfo": {"id": "P00018778"}, "organization": {"fullName": "Boston Children's Hospital", "class": "OTHER"}, "briefTitle": "Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma", "officialTitle": "Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma"}, "statusModule": {"statusVerifiedDate": "2018-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-03"}, "primaryCompletionDateStruct": {"date": "2016-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2016-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2015-07-27", "studyFirstSubmitQcDate": "2015-08-04", "studyFirstPostDateStruct": {"date": "2015-08-06", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-06-21", "resultsFirstSubmitQcDate": "2018-03-03", "resultsFirstPostDateStruct": {"date": "2018-04-02", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-05-08", "lastUpdatePostDateStruct": {"date": "2018-06-07", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Wanda Phipatanakul", "investigatorTitle": "Principle Investigator", "investigatorAffiliation": "Boston Children's Hospital"}, "leadSponsor": {"name": "Boston Children's Hospital", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Background: Pediatric asthma is the most common chronic illness among children and is associated with poor quality of life, activity restriction, school absences, and thousands of physician visits annually. The purpose of this study is to measure the effectiveness of using an innovative tracking system (CareTRx) for the self-management of asthma, including daily and rescue medication use, among children and adolescents with pediatric asthma.", "detailedDescription": "The primary study objective is to measure the effectiveness of using an innovative tracking system (CareTRx) for the self-management of asthma, including daily and rescue medication use, among children with asthma. The study objectives will be achieved using a pre-post design for the participants. The investigators aim to enroll at least 26 participants for a 3-month intervention period. With this pilot study, the investigators hope to examine the impact of self-management behaviors on health outcomes including asthma symptoms and quality of life measures."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "SUPPORTIVE_CARE", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 26, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "CareTRx Device", "type": "EXPERIMENTAL", "description": "Subject will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. The device will track when the rescue inhaler is administered. The information will then be loaded to phone app.", "interventionNames": ["Device: CareTRx"]}], "interventions": [{"type": "DEVICE", "name": "CareTRx", "description": "CareTRx is a novel device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide real-visualize feedback to patients and providers around medication adherence and disease control in pediatric asthma.", "armGroupLabels": ["CareTRx Device"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With Daily Medication Compliance", "description": "Total number participants who took their medication as planned will be measured. This will include measuring the number of participants with medication compliance who take their medications as planned based on the data from the monitoring device.", "timeFrame": "12 weeks"}, {"measure": "Number of Participants With Rescue Inhaler Use", "description": "Total number participants with rescue inhaler use throughout the course of the study.", "timeFrame": "12 weeks"}], "secondaryOutcomes": [{"measure": "Asthma Symptoms", "description": "Asthma symptom control as a measure of effectiveness of self-management behavior on asthma control, measured by Asthma Control Test (ACT). Asthma control test is a survey used to evaluate asthma control in patients. It includes 5 multiple questions that ask about how much of the time patient was having asthma symptoms. The higher the score the better asthma control. Lower scores especially less than 19 represent poor asthma control. each question has 5 answers. The total score is the sum of all the scores from 5 questions. the maximum score on the test is 25 which is excellent asthma control and the lowest is 0 which defines extremely poor asthma control.", "timeFrame": "12 weeks"}, {"measure": "Forced Expiratory Volume", "description": "Forced expiratory volume measured in liters is the volume of air which can be forcibly exhaled from the lungs in the first second of a forced expiration and helps with evaluation of asthma control. FEV1 was only measure at baseline to assess the participants asthma status at baseline.", "timeFrame": "Baseline"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Youth with a primary diagnosis of persistent asthma according by NHLBI criteria\n2. Females or males between the ages of 6-17 years of age\n3. Youth or caregiver must have an Android smart phone with operating system 4.3 or above and data plan for the duration of the study period\n\nExclusion Criteria:\n\n1. Youth with other cardiac, pulmonary, or neuromuscular disorders that impact breathing\n2. Youth with documented developmental delays or impairments that would interfere with ability to use CareTRx system", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "17 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Wanda Phipatanakul, MD, MS", "affiliation": "Boston Children's Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Boston Children's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}]}, "referencesModule": {"references": [{"type": "BACKGROUND", "citation": "U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington DC: U.S. Government Printing Office; 2000."}, {"pmid": "9099758", "type": "BACKGROUND", "citation": "Forrest CB, Starfield B, Riley AW, Kang M. The impact of asthma on the health status of adolescents. Pediatrics. 1997 Feb;99(2):E1. doi: 10.1542/peds.99.2.e1."}, {"pmid": "16094284", "type": "BACKGROUND", "citation": "Centers for Disease Control and Prevention (CDC). Self-reported asthma among high school students--United States, 2003. MMWR Morb Mortal Wkly Rep. 2005 Aug 12;54(31):765-7."}, {"pmid": "12165584", "type": "BACKGROUND", "citation": "Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics. 2002 Aug;110(2 Pt 1):315-22. doi: 10.1542/peds.110.2.315."}, {"type": "BACKGROUND", "citation": "National Asthma Education and Prevention Program. Expert Panel Report II: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; 1997"}, {"type": "BACKGROUND", "citation": "Rapoff, MA. Adherence to pediatric medical regimens, 2nd ed. 2010; New York: Springer"}, {"pmid": "12218770", "type": "BACKGROUND", "citation": "DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002 Sep;40(9):794-811. doi: 10.1097/00005650-200209000-00009."}, {"pmid": "10617735", "type": "BACKGROUND", "citation": "Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics. 2000 Jan;105(1 Pt 3):272-6."}, {"pmid": "21942628", "type": "BACKGROUND", "citation": "Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275-301. doi: 10.1146/annurev-pharmtox-011711-113247. Epub 2011 Sep 19."}, {"type": "BACKGROUND", "citation": "Palermo TM, Wilson AC. eHealth applications in pediatric psychology. In MC Roberts,RG Steele (Eds.), Handbook of pediatric psychology (4th ed., pp. 227-237). 2009. New York: Guilford"}, {"type": "BACKGROUND", "citation": "Atienza AA, Stone AA, Shiffman S, Nebeling L. Introduction. In AA Stone, S Shiffman, AA Atienza, L Nebeling (Eds.), The science of real-time data capture: self-reports in health research. 2007; New York: Oxford"}, {"type": "BACKGROUND", "citation": "Rapoff MA, Lootens CC, Tsai MS. Assessing adherence and barriers to adherence in pediatric asthma. Resp. Drug Deliv. 2012; 1-12"}, {"pmid": "21722917", "type": "BACKGROUND", "citation": "Ingerski LM, Hente EA, Modi AC, Hommel KA. Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. J Pediatr. 2011 Oct;159(4):528-34. doi: 10.1016/j.jpeds.2011.05.018. Epub 2011 Jul 1. No abstract available."}, {"pmid": "17161749", "type": "BACKGROUND", "citation": "Dale O, Hagen KB. Despite technical problems personal digital assistants outperform pen and paper when collecting patient diary data. J Clin Epidemiol. 2007 Jan;60(1):8-17. doi: 10.1016/j.jclinepi.2006.04.005. Epub 2006 Aug 30."}, {"pmid": "12689739", "type": "BACKGROUND", "citation": "Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control Clin Trials. 2003 Apr;24(2):182-99. doi: 10.1016/s0197-2456(02)00320-3."}, {"pmid": "14736583", "type": "BACKGROUND", "citation": "Palermo TM, Valenzuela D, Stork PP. A randomized trial of electronic versus paper pain diaries in children: impact on compliance, accuracy, and acceptability. Pain. 2004 Feb;107(3):213-219. doi: 10.1016/j.pain.2003.10.005."}, {"pmid": "17846042", "type": "BACKGROUND", "citation": "Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008 Oct;33(9):916-36; discussion 937-8. doi: 10.1093/jpepsy/jsm064. Epub 2007 Sep 10."}, {"pmid": "32574599", "type": "DERIVED", "citation": "Behrooz L, Dilley MA, Petty CR, Huffaker MF, Sheehan WJ, Phipatanakul W. The efficacy of a novel monitoring device on asthma control in children with asthma. Ann Allergy Asthma Immunol. 2020 Sep;125(3):352-354. doi: 10.1016/j.anai.2020.06.025. Epub 2020 Jun 20. No abstract available."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "CareTRx Device", "description": "Subject will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. The device will track when the rescue inhaler is administered. The information will then be loaded to phone app.\n\nCareTRx: CareTRx is a novel device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide real-visualize feedback to patients and providers around medication adherence and disease control in pediatric asthma."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "26"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "24"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "CareTRx Device", "description": "Subject will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. The device will track when the rescue inhaler is administered. The information will then be loaded to phone app.\n\nCareTRx: CareTRx is a novel device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide real-visualize feedback to patients and providers around medication adherence and disease control in pediatric asthma."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "26"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "26"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "9.1", "lowerLimit": "6", "upperLimit": "14"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "10"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "16"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "7"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "19"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "12"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "11"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "3"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}]}]}]}, {"title": "Asthma control test", "description": "Asthma control test is a survey used to evaluate asthma control in patients. It includes 5 multiple questions that ask about how much of the time patient was having asthma symptoms. The higher the score the better asthma control. Lower scores especially less than 19 represent poor asthma control. each question has 5 answers. The total score is the sum of all the scores from 5 questions. the maximum score on the test is 25 which is excellent asthma control and the lowest is 0 which defines extremely poor asthma control.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "20.6", "spread": "3.5"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With Daily Medication Compliance", "description": "Total number participants who took their medication as planned will be measured. This will include measuring the number of participants with medication compliance who take their medications as planned based on the data from the monitoring device.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 weeks", "groups": [{"id": "OG000", "title": "CareTRx Device", "description": "All eligible participants will receive CareTRx device for control inhaler as well as the application downloaded to their Android phone. CareTRx is a novel monitoring device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide information to patients and providers around medication adherence and disease control in pediatric asthma. The information will then be loaded to phone app.\n\nAll data in the table represent values collected during the study and no placeholder values were used."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants With Rescue Inhaler Use", "description": "Total number participants with rescue inhaler use throughout the course of the study.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 weeks", "groups": [{"id": "OG000", "title": "CareTRx Device", "description": "All eligible participants will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. CareTRx is a novel monitoring device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide information to patients and providers around medication adherence and disease control in pediatric asthma. The information will then be loaded to phone app.\n\nAll data in the table represent values collected during the study and no placeholder values were used."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptoms", "description": "Asthma symptom control as a measure of effectiveness of self-management behavior on asthma control, measured by Asthma Control Test (ACT). Asthma control test is a survey used to evaluate asthma control in patients. It includes 5 multiple questions that ask about how much of the time patient was having asthma symptoms. The higher the score the better asthma control. Lower scores especially less than 19 represent poor asthma control. each question has 5 answers. The total score is the sum of all the scores from 5 questions. the maximum score on the test is 25 which is excellent asthma control and the lowest is 0 which defines extremely poor asthma control.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "12 weeks", "groups": [{"id": "OG000", "title": "CareTRx Device", "description": "All eligible participants will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. CareTRx is a novel monitoring device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide information to patients and providers around medication adherence and disease control in pediatric asthma. The information will then be loaded to phone app.\n\nAll data in the table represent values collected during the study and no placeholder values were used."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.6", "spread": "3.9"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume", "description": "Forced expiratory volume measured in liters is the volume of air which can be forcibly exhaled from the lungs in the first second of a forced expiration and helps with evaluation of asthma control. FEV1 was only measure at baseline to assess the participants asthma status at baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "CareTRx Device", "description": "All eligible participants will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. CareTRx is a novel monitoring device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide information to patients and providers around medication adherence and disease control in pediatric asthma. The information will then be loaded to phone app.\n\nAll data in the table represent values collected during the study and no placeholder values were used."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.56", "spread": "0.62"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "CareTRx Device", "description": "Subject will receive CareTRx device for rescue inhaler as well as the application downloaded to their Android phone. The device will track when the rescue inhaler is administered. The information will then be loaded to phone app.\n\nCareTRx: CareTRx is a novel device that can be applied to most MDI (meter dose inhaler) device and leverages mobile and cloud computing to objectively assess and provide real-visualize feedback to patients and providers around medication adherence and disease control in pediatric asthma.", "seriousNumAffected": 0, "seriousNumAtRisk": 26, "otherNumAffected": 0, "otherNumAtRisk": 26}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Wanda Phipatanakul", "organization": "Boston Children's Hospital", "email": "wanda.phipatanakul@childrens.harvard.edu", "phone": "6173556117"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}